According to a recent report by the European Commission on the application of competition rules, the pharmaceutical industry is under intense scrutiny, aimed at ensuring access to innovative and affordable medicines, the websites mondaq.com and hengeler-news.com announce. Following the checks carried out by European officials, the cited sources state that several companies have been sanctioned and a series of anticompetitive practices have been discovered, marking significant progress in the